Replies to post #125856 on Biotech Values

[Double_Bagel]

Considering that the short interest is still around 7.5 million shares and Discovery Capital Management has reduced the float by an additional 700k shares. (they already had 1.87M shares). This would imply that the float can't be very high -- less than 10 million if Yahoo is to be believed. We just need some good news for a short squeeze :-)

So, MNTA has now five 5% or higher institutional holders. That has to be good news!

http://finance.yahoo.com/q/mh?s=MNTA+Major+Holders


Top Institutional Holders
Holder Shares % Out Value* Reported
FMR LLC 3,970,314 7.76 77,262,310 Jun 30, 2011

PRICE (T.ROWE) ASSOCIATES INC 3,686,647 7.20 71,742,150 Jun 30, 2011

PALO ALTO INVESTORS, LLC 3,583,602 7.00 69,736,894 Jun 30, 2011

Discovery Capital Management, LLC 1,876,711 3.67 36,520,796 Jun 30, 2011

OPPENHEIMER FUNDS, INC. 5,502,266 10.75 107,074,096 Jun 30, 2011

[DewDiligence]

MNTA Major Shareholders

[Updated for 2Q11 changes.]


The table below shows all shareholders who filed their MNTA holdings
on SEC Form 13-G in Feb 2011 (or later); the holdings are updated each
for filings on Form 13F-HR (except Novartis) and are accurate as of
6/30/11. The percentages in the table are based on 53.3M diluted shares
(#msg-65636329) and do not concur with the percentages on Form 13-G,
which use a different formula. (For insider holdings, see #msg-66636158.)

 
                            Shares    Stake* 
 Oppenheimer               5,502,266  10.3% 
 Novartis                  4,708,679   8.8% 
 Fidelity                  3,970,314   7.4% 
 T Rowe Price              3,686,647   6.9% 
 Palo Alto Investors       3,583,602   6.7% 
 Discovery Capital Mgmt*   2,561,111   4.8% 
 Wellington                2,151,950   4.0% 
 BlackRock                 1,322,370   2.5%

*Form 13-G filed 8/29/11.